Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Neurological Medicine
Volume 2014 (2014), Article ID 372769, 3 pages
http://dx.doi.org/10.1155/2014/372769
Case Report

An Adult Patient with Ocular Myasthenia and Unusually Long Spontaneous Remission

Department of Neurology, Ibn Sina Hospital, P.O. Box 25427, 13115 Safat, Kuwait

Received 4 February 2014; Accepted 31 March 2014; Published 13 April 2014

Academic Editor: N. Scott Litofsky

Copyright © 2014 Jasem Al-Hashel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. S. Schwab and C. C. Leland, “Sex and age in myasthenia gravis as critical factors in incidence and remission (spontaneous and following thymectomy),” Journal of the American Medical Association, vol. 3, pp. 153–158, 1953. View at Google Scholar · View at Scopus
  2. D. Grob, N. G. Brunner, and T. Namba, “The natural course of myasthenia gravis and effect of therapeutic measures,” Annals of the New York Academy of Sciences, vol. 377, pp. 652–669, 1981. View at Google Scholar · View at Scopus
  3. H. J. G. H. Oosterhuis, “The natural course of myasthenia gravis: a long term follow up study,” Journal of Neurology Neurosurgery and Psychiatry, vol. 52, no. 10, pp. 1121–1127, 1989. View at Google Scholar · View at Scopus
  4. M. Rodriguez, M. R. Gomez, F. M. Howard Jr., and W. F. Taylor, “Myasthenia gravis in children: long-term follow-up,” Annals of Neurology, vol. 13, no. 5, pp. 504–510, 1983. View at Google Scholar · View at Scopus
  5. M. J. Kupersmith, “Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up,” Journal of Neurology, vol. 256, no. 8, pp. 1314–1320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. H. J. Kaminski and R. B. Daroff, “Treatment of ocular myasthenia: steroids only when compelled,” Archives of Neurology, vol. 57, no. 5, pp. 752–753, 2000. View at Google Scholar · View at Scopus
  7. J. A. Simpson, “An evaluation of thymectomy in myasthenia gravis,” Brain, vol. 81, no. 1, pp. 112–144, 1958. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Mano, T. Takegami, S. Okamoto, and A. Takahashi, “Remission of myasthenia gravis: clinical, electrophysiological and immunological studies,” Nagoya Journal of Medical Science, vol. 55, no. 1–4, pp. 103–113, 1993. View at Google Scholar · View at Scopus
  9. A. Kostera-Pruszczyk, B. Emeryk-Szajewska, J. Witalska et al., “Clinical, electrophysiological and immunological remissions after thymectomy in myasthenia gravis,” Clinical Neurophysiology, vol. 113, no. 4, pp. 615–619, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. V. C. Juel and J. M. Massey, “Myasthenia gravis,” Orphanet Journal of Rare Diseases, vol. 2, no. 1, article 44, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Brenner, Y. Hamra-Amitay, T. Evron, N. Boneva, S. Seidman, and H. Soreq, “The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis,” The FASEB Journal, vol. 17, no. 2, pp. 214–222, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Lev-Lehman, T. Evron, R. S. Broide et al., “Synaptogenesis and myopathy under acetylcholinesterase overexpression,” Journal of Molecular Neuroscience, vol. 14, no. 1-2, pp. 93–105, 2000. View at Google Scholar · View at Scopus
  13. R. D. Rollinson and G. M. Fenichel, “Relapsing ocular myasthenia,” Neurology, vol. 31, no. 3, pp. 325–326, 1981. View at Google Scholar · View at Scopus
  14. S. Ortiz and M. Borchert, “Long-term outcomes of pediatric ocular myasthenia gravis,” Ophthalmology, vol. 115, no. 7, pp. 1245–1248, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Anlar, V. Yilmaz, and G. Saruhan-Direskeneli, “Long remission in muscle-specific kinase antibody-positive juvenile myasthenia,” Pediatric Neurology, vol. 40, no. 6, pp. 455–456, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. V. A. Lennon, J. M. Lindstrom, and M. E. Seybold, “Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs,” Journal of Experimental Medicine, vol. 141, no. 6, pp. 1365–1375, 1975. View at Google Scholar · View at Scopus
  17. B. Wu, E. Goluszko, R. Huda, E. Tüzün, and P. Christadoss, “Experimental autoimmune myasthenia gravis in the mouse,” Current Protocols in Immunology, 2011. View at Publisher · View at Google Scholar
  18. S. Shenhar-Tsarfaty, S. Berliner, N. M. Bornstein, and H. Soreq, “Cholinesterases as biomarkers for parasympathetic dysfunction and inflammation-related disease,” Journal of Molecular Neuroscience, 2013. View at Publisher · View at Google Scholar
  19. M. N. Meriggioli and D. B. Sanders, “Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity,” The Lancet Neurology, vol. 8, no. 5, pp. 475–490, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Serra, R. L. Ruff, and R. J. Leigh, “Neuromuscular transmission failure in myasthenia gravis: decrement of safety factor and susceptibility of extraocular muscles,” Annals of the New York Academy of Sciences, vol. 1275, pp. 129–135, 2012. View at Google Scholar